HERE FOR 20 YEARS FOR PEOPLE WITH AN INTEREST IN MULTIPLE SCLEROSIS Skip to content

Stem cell transplantation to treat MS (JAMA editorial, article)

565 Views 1 Replies

0 Members and 1 Guest are viewing this topic.

#1
An editorial in JAMA by Harold Atkins, MD, of the Ottawa Hospital Research Institute (January 15, 2019--"Stem cell transplantation to treat multiple sclerosis":


https://jamanetwork.com/journals/jama/fullarticle/2720713?guestAccessKey=8cc989d3-fbd0-4ab6-92d4-471190e813a9&utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jama&utm_content=etoc&utm_term=011519


An article in the same issue, "Effect of nonmyeloablative hematopoietic stem cell transplantation vs continued disease modifying therapy on disease progression in patients with relapsing-remitting multiple sclerosis: A randomized clinical trial" by Richard K. Burt, MD, of Northwestern University:


https://jamanetwork.com/journals/jama/fullarticle/2720728?guestAccessKey=6b4d7a45-ed01-4cbf-860d-0a4bb41f8211&utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jama&utm_content=etoc&utm_term=011519
Last Edit: January 15, 2019, 07:37:48 pm by agate
MS Speaks--online for 20 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week)  12/16/20 - 3/16/24.
Stem cell transplant effective for select MS patients
Reply #1 on:
#2
More on this, in MedPage Today (January 15, 2019)--"Stem cell transplant effective for select MS patients":


Lesion load, disability improved for relapsing patients with highly active MS
medpagetoday.com
MS Speaks--online for 20 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week)  12/16/20 - 3/16/24.